Albireo to participate in the needham 20th annual virtual healthcare conference

Boston, april 06, 2021 (globe newswire) -- albireo pharma, inc. (nasdaq: albo), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced participation in the upcoming needham 20th annual healthcare conference on april 12-15. albireo executives taking part will include ron cooper, president and chief executive officer and simon harford, chief financial officer. the team will participate in a fireside chat on april 13 at 9:30 a.m. et, which will be available on-demand on the albireo media & investors page at ir.albireopharma.com, as well as hosting meeting with investors throughout the conference.
ALBO Ratings Summary
ALBO Quant Ranking